Lexeo Therapeutics, Inc.
Tobin Schilke (Director) reports LXEO insider transactions
About this filing
Lexeo Therapeutics, Inc. (LXEO) filed Form 4 (insider transaction) with the SEC on Nov 17, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Tobin Schilke · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 14, 2026 | A · grantStock Option (right to buy)Footnotes F1 | +70,000 | $0.00 | $0.00 | 70,000 | Direct |
Footnotes
- F1 1/3rd of the shares underlying the option shall vest, and become exercisable, on each yearly anniversary of the Grant Date, such that all shares are vested and exercisable on November 14, 2029, subject to the Reporting Person's continuous service on each such vesting date.
More LXEO filings
- 3
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- SC 13G/A
Filed Nov 16, 2026
- SC 13G/A
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.